Key result
Minimally invasive aortic valve replacement resulted in comparable early mortality to conventional replacement (1.8% vs 3.0%; OR 0.70; 95% CI 0.46-1.06; p=0.09) despite longer ischemic times.
Why the study?
Does minimally invasive aortic valve replacement improve clinical outcomes compared to conventional aortic valve replacement in patients undergoing AVR?
Population
4,670 patients from 18 studies undergoing aortic valve replacement
Comparison
Minimally invasive aortic valve replacement (mAVR) vs Conventional aortic valve replacement (cAVR)
Design
Meta-analysis
Follow-up
early postoperative period
Authors
Loading...
Supports minimally invasive AVR as a safe alternative; strengthens Level 1 evidence of early mortality equivalence despite longer ischemic times.
Meta-Analysis (n=4,670)
Does minimally invasive aortic valve replacement improve clinical outcomes compared to conventional aortic valve replacement in patients undergoing AVR?
Odds Ratio: 0.7 (95% CI 0.46–1.06)
Absolute Event Rate: 1.8% vs 3%
p-value: p=0.09
Minimally invasive AVR is safe and associated with earlier hospital discharge compared to conventional AVR, despite longer ischemic times, but does not significantly reduce early mortality, transfusion requirements, or pain.
Lim et al. (2014) conducted a meta-analysis in Aortic valve replacement (n=4,670). Minimally invasive aortic valve replacement (mAVR) vs. Conventional aortic valve replacement (cAVR) was evaluated on Early mortality (OR 0.70, 95% CI 0.46-1.06, p=0.09). Minimally invasive aortic valve replacement resulted in comparable early mortality to conventional replacement (1.8% vs 3.0%; OR 0.70; 95% CI 0.46-1.06; p=0.09) despite longer ischemic times.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: